Department of Biomedical Engineering
Friedrich-Alexander-University Erlangen-Nuremberg
Henkestrasse 91, D-91052 Erlangen, Germany

Phone: +49 (0) 9131 85-25630
Fax: +49 (0) 9131 85-25631

The Department of Biomedical Engineering is a statutory body
in the Friedrich-Alexander-University Erlangen-Nuremberg.
The statutory representative is Prof. Dr. Bernhard Hensel.

Competent supervisory authority:
Bayerisches Staatsministerium für Wissenschaft, Forschung und Kunst

Editor responsible for the content according to § 6 MDStV:
Prof. Dr. Bernhard Hensel

Copyrights and liability:
The layout of the homepage, the graphics it contains, as well as the collection of documents are protected by copyright. Reproduction of these pages is authorized exclusively for personal use, no alterations are permitted, and any reproduced material may not be disseminated or displayed in public. All individual documents are likewise protected by copyright. All information on this server is provided without guarantee as to its accuracy. Under no circumstances will liability be assumed for loss or damage sustained through use of the information provided.

Important note:
Medicine and biomedical engineering are ever-changing sciences undergoing continual development. Research and clinical experience are continually expanding our knowledge, in particular our knowledge of proper treatment and drug therapy. Insofar as this journal mentions any dosage or application, readers may be confident that the authors, editors, and publishers have made every effort to ensure that such references are in accordance with the present state of knowledge at the time this journal is published. Nevertheless, this does not involve, imply, or express any guarantee or responsibility on the part of the publishers in respect to any dosage instructions and forms of application stated in the journal. Every user is requested to carefully examine the manufacturer's "Instructions for Use" that accompany each drug, as well as leaflets accompanying each drug, and to check, if necessary in consultation with a physician or specialist, whether the dosage schedules mentioned therein or the contraindications stated by the manufacturer differ from the statements made in the present journal. Such examination is particularly important with drugs that are either rarely used or have been newly released on the market. Every dosage schedule and every form of application used is entirely at the user's own risk and responsibility. The editors and authors request that readers report any discrepancies or inaccuracies directly to the publishers.